세계의 전임상 동물 텔레메트리 시장(2024-2028년)

Abstract

The preclinical animal telemetry market is forecasted to grow by USD 21.55 mn during 2023-2028, accelerating at a CAGR of 5.69% during the forecast period. The report on the preclinical animal telemetry market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing growth in preclinical research and testing, growing demand for lowering attrition rate in translational research, and increase in product launches of preclinical animal telemetry.

Technavio's preclinical animal telemetry market is segmented as below:

By End-user

• Industrial laboratories and CROs
• Academic government
• other research laboratories

By Type

• Small animal telemetry
• Large animal telemetry

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advances in animal telemetry systems as one of the prime reasons driving the preclinical animal telemetry market growth during the next few years. Also, growing focus on developing send-compatible software and growing focus on collaboration and partnerships will lead to sizable demand in the market.

The report on the preclinical animal telemetry market covers the following areas:

• Preclinical animal telemetry market sizing
• Preclinical animal telemetry market forecast
• Preclinical animal telemetry market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading preclinical animal telemetry market vendors that include ADInstruments Pty Ltd., Advanced Telemetry Systems Inc., BIO RESEARCH CENTER Co. Ltd., BIOPAC Systems Inc., Cambridge NeuroTech, Charles River Laboratories International Inc., Ecotone Goc, emka TECHNOLOGIES, ETISENSE SAS, Harvard Bioscience Inc., Indus Instruments, Instem Plc, Kent Scientific Corp., Muromachi Kikai Co. Ltd., Somark Innovations, Star Oddi hf, Starr Life Sciences Corp., Telemetry Solutions Inc., TSE Systems GmbH, and Vivonics Preclinical Ltd.. Also, the preclinical animal telemetry market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global preclinical animal telemetry market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global preclinical animal telemetry market 2018 - 2022 ($ million)
• 4.2 End-user Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• 4.3 Type Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

• 6.1 Market segments
• Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
• Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
• 6.2 Comparison by End-user
• Exhibit 32: Chart on Comparison by End-user
• Exhibit 33: Data Table on Comparison by End-user
• 6.3 Industrial laboratories and CROs - Market size and forecast 2023-2028
• Exhibit 34: Chart on Industrial laboratories and CROs - Market size and forecast 2023-2028 ($ million)
• Exhibit 35: Data Table on Industrial laboratories and CROs - Market size and forecast 2023-2028 ($ million)
• Exhibit 36: Chart on Industrial laboratories and CROs - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Industrial laboratories and CROs - Year-over-year growth 2023-2028 (%)
• 6.4 Academic government and other research laboratories - Market size and forecast 2023-2028
• Exhibit 38: Chart on Academic government and other research laboratories - Market size and forecast 2023-2028 ($ million)
• Exhibit 39: Data Table on Academic government and other research laboratories - Market size and forecast 2023-2028 ($ million)
• Exhibit 40: Chart on Academic government and other research laboratories - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Academic government and other research laboratories - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by End-user
• Exhibit 42: Market opportunity by End-user ($ million)
• Exhibit 43: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Type

• 7.1 Market segments
• Exhibit 44: Chart on Type - Market share 2023-2028 (%)
• Exhibit 45: Data Table on Type - Market share 2023-2028 (%)
• 7.2 Comparison by Type
• Exhibit 46: Chart on Comparison by Type
• Exhibit 47: Data Table on Comparison by Type
• 7.3 Small animal telemetry - Market size and forecast 2023-2028
• Exhibit 48: Chart on Small animal telemetry - Market size and forecast 2023-2028 ($ million)
• Exhibit 49: Data Table on Small animal telemetry - Market size and forecast 2023-2028 ($ million)
• Exhibit 50: Chart on Small animal telemetry - Year-over-year growth 2023-2028 (%)
• Exhibit 51: Data Table on Small animal telemetry - Year-over-year growth 2023-2028 (%)
• 7.4 Large animal telemetry - Market size and forecast 2023-2028
• Exhibit 52: Chart on Large animal telemetry - Market size and forecast 2023-2028 ($ million)
• Exhibit 53: Data Table on Large animal telemetry - Market size and forecast 2023-2028 ($ million)
• Exhibit 54: Chart on Large animal telemetry - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Large animal telemetry - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by Type
• Exhibit 56: Market opportunity by Type ($ million)
• Exhibit 57: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 61: Chart on Geographic comparison
• Exhibit 62: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 UK - Market size and forecast 2023-2028
• Exhibit 83: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 84: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 85: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.9 Germany - Market size and forecast 2023-2028
• Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.10 France - Market size and forecast 2023-2028
• Exhibit 91: Chart on France - Market size and forecast 2023-2028 ($ million)
• Exhibit 92: Data Table on France - Market size and forecast 2023-2028 ($ million)
• Exhibit 93: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on France - Year-over-year growth 2023-2028 (%)
• 9.11 Japan - Market size and forecast 2023-2028
• Exhibit 95: Chart on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibit 96: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibit 97: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 99: Market opportunity By Geographical Landscape ($ million)
• Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 101: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 103: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 104: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 105: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 106: Matrix on vendor position and classification
• 12.3 ADInstruments Pty Ltd.
• Exhibit 107: ADInstruments Pty Ltd. - Overview
• Exhibit 108: ADInstruments Pty Ltd. - Product / Service
• Exhibit 109: ADInstruments Pty Ltd. - Key offerings
• 12.4 BIO RESEARCH CENTER Co. Ltd.
• Exhibit 110: BIO RESEARCH CENTER Co. Ltd. - Overview
• Exhibit 111: BIO RESEARCH CENTER Co. Ltd. - Product / Service
• Exhibit 112: BIO RESEARCH CENTER Co. Ltd. - Key offerings
• 12.5 BIOPAC Systems Inc.
• Exhibit 113: BIOPAC Systems Inc. - Overview
• Exhibit 114: BIOPAC Systems Inc. - Product / Service
• Exhibit 115: BIOPAC Systems Inc. - Key offerings
• 12.6 Cambridge NeuroTech
• Exhibit 116: Cambridge NeuroTech - Overview
• Exhibit 117: Cambridge NeuroTech - Product / Service
• Exhibit 118: Cambridge NeuroTech - Key offerings
• 12.7 emka TECHNOLOGIES
• Exhibit 119: emka TECHNOLOGIES - Overview
• Exhibit 120: emka TECHNOLOGIES - Product / Service
• Exhibit 121: emka TECHNOLOGIES - Key offerings
• 12.8 ETISENSE SAS
• Exhibit 122: ETISENSE SAS - Overview
• Exhibit 123: ETISENSE SAS - Product / Service
• Exhibit 124: ETISENSE SAS - Key offerings
• 12.9 Harvard Bioscience Inc.
• Exhibit 125: Harvard Bioscience Inc. - Overview
• Exhibit 126: Harvard Bioscience Inc. - Product / Service
• Exhibit 127: Harvard Bioscience Inc. - Key offerings
• 12.10 Indus Instruments
• Exhibit 128: Indus Instruments - Overview
• Exhibit 129: Indus Instruments - Product / Service
• Exhibit 130: Indus Instruments - Key offerings
• 12.11 Instem Plc
• Exhibit 131: Instem Plc - Overview
• Exhibit 132: Instem Plc - Product / Service
• Exhibit 133: Instem Plc - Key offerings
• 12.12 Muromachi Kikai Co. Ltd.
• Exhibit 134: Muromachi Kikai Co. Ltd. - Overview
• Exhibit 135: Muromachi Kikai Co. Ltd. - Product / Service
• Exhibit 136: Muromachi Kikai Co. Ltd. - Key offerings
• 12.13 Somark Innovations
• Exhibit 137: Somark Innovations - Overview
• Exhibit 138: Somark Innovations - Product / Service
• Exhibit 139: Somark Innovations - Key offerings
• 12.14 Star Oddi hf
• Exhibit 140: Star Oddi hf - Overview
• Exhibit 141: Star Oddi hf - Product / Service
• Exhibit 142: Star Oddi hf - Key offerings
• 12.15 Starr Life Sciences Corp.
• Exhibit 143: Starr Life Sciences Corp. - Overview
• Exhibit 144: Starr Life Sciences Corp. - Product / Service
• Exhibit 145: Starr Life Sciences Corp. - Key offerings
• 12.16 TSE Systems GmbH
• Exhibit 146: TSE Systems GmbH - Overview
• Exhibit 147: TSE Systems GmbH - Product / Service
• Exhibit 148: TSE Systems GmbH - Key offerings
• 12.17 Vivonics Preclinical Ltd.
• Exhibit 149: Vivonics Preclinical Ltd. - Overview
• Exhibit 150: Vivonics Preclinical Ltd. - Product / Service
• Exhibit 151: Vivonics Preclinical Ltd. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 152: Inclusions checklist
• Exhibit 153: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 154: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 155: Research methodology
• Exhibit 156: Validation techniques employed for market sizing
• Exhibit 157: Information sources
• 13.5 List of abbreviations
• Exhibit 158: List of abbreviations